SCHEMBL3605744

SCHEMBL3605744

O=C(O)NCC1CCN(CCCc2cc(-c3ccc(Cl)cc3)on2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 2/20 0.44
POLB P06746 2/20 0.44
MAPT P10636 2/20 0.44
NOTUM Q6P988 1/20 0.44
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
DRD2 P14416 1/20 0.43
DRD4 P21917 1/20 0.43
DRD3 P35462 1/20 0.43
CYP1A2 P05177 1/20 0.42
GAA P10253 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
KDM1A O60341 2/20 0.42
HDAC6 Q9UBN7 2/20 0.42
HTT P42858 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
AVPR1B P47901 1/20 0.42
ALDH1A1 P00352 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3594726 0.94 HIF1A (0.46) HIF1APOLBMAPTNOTUMNPC1
SCHEMBL3594357 0.83 USP30 (0.49) POLBNOTUMDRD2DRD4DRD3
SCHEMBL3605749 0.80 NOTUM (0.44) POLBMAPTNOTUMNPC1RAB9A
SCHEMBL5486911 0.80 NOTUM (0.50) POLBMAPTNOTUMNPC1RAB9A
SCHEMBL2981434 0.80 POLB (0.41) POLBMAPTNOTUMNPC1RAB9A
SCHEMBL3593611 0.79 USP30 (0.50) POLBNOTUMDRD2DRD4DRD3
SCHEMBL5709441 0.79 MAPT (0.45) POLBMAPTNOTUMNPC1RAB9A
SCHEMBL2837084 0.79 NOTUM (0.56) POLBMAPTNOTUMNPC1RAB9A
SCHEMBL2981428 0.78 MAPT (0.43) POLBMAPTNOTUMNPC1RAB9A
SCHEMBL2844564 0.78 NOTUM (0.55) HIF1APOLBMAPTNOTUMNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1720550-B1 DERIVATIVES OF PIPERIDINYLALKYLCARBAMATES, PREPARATION METHOD THEREOF AND USE OF SAME AS FAAH ENZYME INHIBITORS SANOFI AVENTIS (FR) 2009-04-15 EP claimed
US-20100279998-A1 PIPERIDINYLALKYLCARBAMATE DERIVATIVES, METHODS FOR THEIR PREPARATION AND THE THERAPEUTIC USE THEREOF AS FATTY ACID AMIDO HYDROLASE ENZYME INHIBITORS SANOFI-AVENTIS (FR) 2010-11-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100279998-A1 PIPERIDINYLALKYLCARBAMATE DERIVATIVES, METHODS FOR THEIR PREPARATION AND THE THERAPEUTIC USE THEREOF AS FATTY ACID AMIDO HYDROLASE ENZYME INHIBITORS FAAH, FAAH2, CNR2 HIF1A 2195/4885POLB 2745/4885MAPT 4557/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.